SB3801 allows labels on mifepristone, misoprostol, and generic alternatives to list the dispensing health care practice instead of the individual.
SB3801 amends the Medical Practice Act of 1987 and the Pharmacy Practice Act to allow labels on packages containing mifepristone, misoprostol, or any generic alternatives to include the name of the dispensing health care practice instead of the individual prescriber. This change applies at the request of the person dispensing the drug or medicine. The bill also specifies that the label must include the name and address of the pharmacy, the date the prescription was filled, the patient's name, and the directions for use.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.